Article

Economic burden of kidney cancer eased by robotics

Adoption of robotic surgery for treatment of kidney cancer has led to a modest increase in the annual volume of partial nephrectomies but a substantial cost savings for care of chronic kidney disease, an economic analysis of a 6-year period suggests.

Newsletter

Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.

© 2025 MJH Life Sciences

All rights reserved.